FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ewa Nizankowska

Research Profile

Disorders

Chemicals & Drugs

Procedures

Phenomena

Anatomy

Co-author Network

Publications

TOP 3
Grazyna Bochenek; Ewa Nizankowska; Anna Gielicz; Andrew Szczeklik
Mast cell activation after adenosine inhalation challenge in patients with bronchial asthma.
Marek Sanak; Daniel P Potaczek; Lucyna Mastalerz; Ewa Nizankowska; Andrew Szczeklik
FCERIA gene promoter polymorphisms: lack of association with aspirin hypersensitivity in whites.
Daniel P Potaczek; Marek Sanak; Ewa Nizankowska; Lucyna Mastalerz; Sylwia Dziedzina; Marek Grzywacz; Andrew Szczeklik
Novel exon 2A of the high-affinity receptor for the IgE alpha-chain gene (FCER1A) and autoimmunity in patients with asthma or urticaria.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ewa Nizankowska (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Grazyna Bochenek; Ewa Nizankowska; Anna Gielicz; Andrew Szczeklik
Mast cell activation after adenosine inhalation challenge in patients with bronchial asthma.
Allergy 2008;63(1):140-1.
2007: Marek Sanak; Daniel P Potaczek; Lucyna Mastalerz; Ewa Nizankowska; Andrew Szczeklik
FCERIA gene promoter polymorphisms: lack of association with aspirin hypersensitivity in whites.
The Journal of allergy and clinical immunology 2007;119(5):1280-1.
2006: Daniel P Potaczek; Marek Sanak; Ewa Nizankowska; Lucyna Mastalerz; Sylwia Dziedzina; Marek Grzywacz; Andrew Szczeklik
Novel exon 2A of the high-affinity receptor for the IgE alpha-chain gene (FCER1A) and autoimmunity in patients with asthma or urticaria.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2006;97(5):711-2.
2006: Daniel P Potaczek; Marek Sanak; Lucyna Mastalerz; Malgorzata Setkowicz; Marcin P Kaczor; Ewa Nizankowska; Andrew Szczeklik
The alpha-chain of high-affinity receptor for IgE (FcepsilonRIalpha) gene polymorphisms and serum IgE levels.
Allergy 2006;61(10):1230-3.
2004: Grazyna Bochenek; Ewa Nizankowska; Anna Gielicz; M Swierczyńska; Andrew Szczeklik
Plasma 9alpha,11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma.
Thorax 2004;59(6):459-64.
2004: Pawel Strek; Olaf Zagólski; Monika Swierczyńska; Ewa Nizankowska; Marta Szałapata-Kraśniak
[Functional assessment of posterior cordotomy in patients with bilateral vocal fold paralysis].
Otolaryngologia polska. The Polish otolaryngology 2004;58(3):451-7.
2003: Pär Gyllfors; Grazyna Bochenek; John Overholt; Diane Drupka; Maria Kumlin; James R Sheller; Ewa Nizankowska; Peter C Isakson; Filip Mejza; James B Lefkowith; Sven-Erik Dahlén; Andrew Szczeklik; John Joseph Murray; Barbro Dahlén
Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib.
The Journal of allergy and clinical immunology 2003;111(5):1116-21.
2003: Grazyna Bochenek; Krzysztof Nagraba; Ewa Nizankowska; Andrew Szczeklik
A controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge.
The Journal of allergy and clinical immunology 2003;111(4):743-9.
2002: Lucyna Mastalerz; Ewa Nizankowska; Marek Sanak; Filip Mejza; Malgorzata Pierzchalska; Stanislawa Bazan-Socha; A Bestynska-Krypel; Adam Cmiel; Andrew Szczeklik
Clinical and genetic features underlying the response of patients with bronchial asthma to treatment with a leukotriene receptor antagonist.
European journal of clinical investigation 2002;32(12):949-55.
2002: Lucyna Mastalerz; Agnieszka Gawlewicz-Mroczka; Ewa Nizankowska; Adam Cmiel; Andrew Szczeklik
Protection against exercise-induced bronchoconstriction by montelukast in aspirin-sensitive and aspirin-tolerant patients with asthma.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2002;32(9):1360-5.
2002: Teresa B Domagala; Lukasz Adamek; Ewa Nizankowska; Marek Sanak; Andrew Szczeklik
Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002;13(5):423-31.
2002: Andrew Szczeklik; Ewa Nizankowska; Lucyna Mastalerz; Zsuzsanna Szabo
Analgesics and asthma.
American journal of therapeutics 2002;9(3):233-43.
2002: Grazyna Bochenek; K Bánska; Z Szabó; Ewa Nizankowska; Andrew Szczeklik
Diagnosis, prevention and treatment of aspirin-induced asthma and rhinitis.
Current drug targets. Inflammation and allergy 2002;1(1):1-11.
2002: Andrew Szczeklik; Ewa Nizankowska; Lucyna Mastalerz; Grazyna Bochenek
Myocardial ischemia possibly mediated by cysteinyl leukotrienes.
The Journal of allergy and clinical immunology 2002;109(3):572-3.
2002: Sven-Erik Dahlén; Kerstin Malmström; Ewa Nizankowska; Barbro Dahlén; Piotr Kuna; Marek Kowalski; William Lumry; César Picado; Donald D Stevenson; Jean Bousquet; Romain Pauwels; Stephen T Holgate; Aditi Shahane; Ji Zhang; Theodore F Reiss; Andrew Szczeklik
Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
American journal of respiratory and critical care medicine 2002;165(1):9-14.
2001: A Szczeklik; Lucyna Mastalerz; Ewa Nizankowska; Marek Sanak
Montelukast for persistent asthma.
Lancet 2001;358(9291):1456-7.
2001: Andrew Szczeklik; Ewa Nizankowska; Marek Sanak; Monika Swierczynska
Aspirin-induced rhinitis and asthma.
Current opinion in allergy and clinical immunology 2001;1(1):27-33.
2001: Andrew Szczeklik; Ewa Nizankowska; Grazyna Bochenek; Krzysztof Nagraba; Filip Mejza; Monika Swierczynska
Safety of a specific COX-2 inhibitor in aspirin-induced asthma.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2001;31(2):219-25.
2001: Filip Mejza; Ewa Nizankowska
[Selective cyclooxygenase 2 inhibitors (COX-2)].
Postȩpy higieny i medycyny doświadczalnej 2001;55(2):287-302.
2000: Andrew Szczeklik; Ewa Nizankowska
Clinical features and diagnosis of aspirin induced asthma.
Thorax 2000;55 Suppl 2():S42-4.
2000: Andrew Szczeklik; Ewa Nizankowska; Mariusz Duplaga
Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2000;16(3):432-6.
2000: Ewa Nizankowska; A Bestyńska-Krypel; Adam Cmiel; Andrew Szczeklik
Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2000;15(5):863-9.
1999: Lukasz Adamek; M Jankowski; Marek Sanak; Marek Krzanowski; Piotr Grzanka; Ewa Nizankowska; Andrew Szczeklik
[Coincidence of 20210A prothrombin variant and factor V Leiden predisposing to venous thromboembolism].
Polskie Archiwum Medycyny Wewnętrznej 1999;102(6):1095-9.
1999: Piotr Grzanka; P Marcinek; P Czaja; Lukasz Adamek; C Olszewski; Ewa Nizankowska; Andrew Szczeklik
[Spiral computed tomography in diagnosis of pulmonary embolism].
Polskie Archiwum Medycyny Wewnętrznej 1999;101(5):437-44.
1998: Andrew Szczeklik; Ryszard Dworski; Lucyna Mastalerz; A Prokop; James R Sheller; Ewa Nizankowska; Adam Cmiel; John A Oates
Salmeterol prevents aspirin-induced attacks of asthma and interferes with eicosanoid metabolism.
American journal of respiratory and critical care medicine 1998;158(4):1168-72.
1998: Mamert Milewski; Lucyna Mastalerz; Ewa Nizankowska; Andrew Szczeklik
Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma.
The Journal of allergy and clinical immunology 1998;101(5):581-6.
1998: Barbro Dahlén; Ewa Nizankowska; Andrew Szczeklik; Olle Zetterström; Grazyna Bochenek; Maria Kumlin; Lucyna Mastalerz; G Pinis; LJ Swanson; T I Boodhoo; S Wright; LM Dubé; Sven-Erik Dahlén
Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.
American journal of respiratory and critical care medicine 1998;157(4 Pt 1):1187-94.
1998: AS Cowburn; Krzysztof Sladek; Jerzy Soja; Lukasz Adamek; Ewa Nizankowska; Andrew Szczeklik; Bing K Lam; John F Penrose; F K Austen; Stephen T Holgate; Tony Sampson
Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma.
The Journal of clinical investigation 1998;101(4):834-46.
1997: Lucyna Mastalerz; Mamert Milewski; Mariusz Duplaga; Ewa Nizankowska; Andrew Szczeklik
Intranasal fluticasone propionate for chronic eosinophilic rhinitis in patients with aspirin-induced asthma.
Allergy 1997;52(9):895-900.
1997: J W Dekker; Ewa Nizankowska; M Schmitz-Schumann; K Pile; Grazyna Bochenek; A Dyczek; William O C M Cookson; Andrew Szczeklik
Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1997;27(5):574-7.
1997: Tony Sampson; AS Cowburn; Krzysztof Sladek; Lukasz Adamek; Ewa Nizankowska; Andrew Szczeklik; Bing K Lam; John F Penrose; K Frank Austen; Stephen T Holgate
Profound overexpression of leukotriene C4 synthase in bronchial biopsies from aspirin-intolerant asthmatic patients.
International archives of allergy and immunology 1997;113(1-3):355-7.
1996: Andrew Szczeklik; Krzysztof Sladek; Ryszard Dworski; Ewa Nizankowska; Jerzy Soja; James R Sheller; J Oates
Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics.
American journal of respiratory and critical care medicine 1996;154(6 Pt 1):1608-14.
1996: A Guzdek; Ewa Nizankowska; A C Allison; P B Kruger; Aleksander Koj
Cytokine production in human and rat macrophages and dicatechol rooperol and esters.
Biochemical pharmacology 1996;52(7):991-8.
1996: Lukasz Adamek; K Sładek; Ewa Nizankowska
[Cough as an adverse effect during angiotensin-converting enzyme inhibitor therapy].
Polskie Archiwum Medycyny Wewnętrznej 1996;95(3):254-60.
1996: Grazyna Bochenek; Ewa Nizankowska
[Genetic aspects of atopic diseases].
Polskie Archiwum Medycyny Wewnętrznej 1996;95(2):160-5.
1996: Andrew Szczeklik; Lucyna Mastalerz; Ewa Nizankowska; A Cmiel
Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma.
American journal of respiratory and critical care medicine 1996;153(2):567-71.
1996: Lucyna Mastalerz; Ewa Nizankowska
[Nasal provocation tests].
Pneumonologia i alergologia polska 1996;64(3-4):229-34.
1996: G Pinis; Lukasz Adamek; Ewa Nizankowska
[Diagnosis and treatment of chronic cough].
Pneumonologia i alergologia polska 1996;64(3-4):115-22.
1996: Grazyna Bochenek; Ewa Nizankowska; Andrew Szczeklik
The atopy trait in hypersensitivity to nonsteroidal anti-inflammatory drugs.
Allergy 1996;51(1):16-23.
1995: Andrew Szczeklik; Ewa Nizankowska; A Serafin; A Dyczek; Mariusz Duplaga; Jacek Musial
Autoimmune phenomena in bronchial asthma with special reference to aspirin intolerance.
American journal of respiratory and critical care medicine 1995;152(6 Pt 1):1753-6.
1995: Ewa Nizankowska; Jerzy Soja; G Pinis; Grazyna Bochenek; K Sładek; B Domagała; Andrzej Pajak; Andrew Szczeklik
Treatment of steroid-dependent bronchial asthma with cyclosporin.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1995;8(7):1091-9.
1994: Krzysztof Sladek; Ryszard Dworski; Jerzy Soja; James R Sheller; Ewa Nizankowska; J A Oates; Andrew Szczeklik
Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge.
American journal of respiratory and critical care medicine 1994;149(4 Pt 1):940-6.
1992: Andrew Szczeklik; Ewa Nizankowska; Krzysztof Sladek
Cyclosporin and asthma.
Lancet 1992;339(8797):873.
1992: Andrew Szczeklik; M Schmitz-Schumann; Ewa Nizankowska; M Milewski; F Roehlig; C Virchow
Altered distribution of IgG subclasses in aspirin-induced asthma: high IgG4, low IgG1.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1992;22(2):283-7.
1991: Andrew Szczeklik; Ewa Nizankowska; Ryszard Dworski; B Domagala; G Pinis
Cyclosporin for steroid-dependent asthma.
Allergy 1991;46(4):312-5.
1991: Ewa Nizankowska; Ryszard Dworski; A Szczeklik
Cyclosporin for a severe case of aspirin-induced asthma.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1991;4(3):380.
1990: Ewa Nizankowska; Ryszard Dworski; Jerzy Soja; Andrew Szczeklik
Salicylate pre-treatment attenuates intensity of bronchial and nasal symptoms precipitated by aspirin in aspirin-intolerant patients.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1990;20(6):647-52.
1990: A Szczeklik; Ewa Nizankowska; Ryszard Dworski
Choline magnesium trisalicylate in patients with aspirin-induced asthma.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1990;3(5):535-9.
1989: Ewa Nizankowska; Andrew Szczeklik
Glucocorticosteroids attenuate aspirin-precipitated adverse reactions in aspirin-intolerant patients with asthma.
Annals of allergy 1989;63(2):159-62.
1988: Ewa Nizankowska; Z Michalska; M Wandzilak; M Radomski; Ewa Marcinkiewicz; Ryszard J Gryglewski; Andrew Szczeklik
An abnormality of arachidonic acid metabolism is not a generalized phenomenon in patients with aspirin-induced asthma.
Eicosanoids 1988;1(1):45-8.
1987: Andrew Szczeklik; Ewa Nizankowska; Jacek Splawinski; Ryszard Dworski; P Gajewski; B Splawinska
Effects of inhibition of thromboxane A2 synthesis in aspirin-induced asthma.
The Journal of allergy and clinical immunology 1987;80(6):839-43.
1987: Andrew Szczeklik; Marek Krzanowski; Ewa Nizankowska; Jacek Musial
Bleeding time and PAF-acether-induced platelet aggregation in atopy.
Agents and actions. Supplements 1987;21():145-50.
1987: Ewa Nizankowska; G Czerniawska-Mysik; Andrew Szczeklik
The effect of prostacyclin on asthma precipitated by aspirin.
Allergie et immunologie 1987;19(1):22-4.
1987: Ewa Nizankowska; A Q Sheridan; M H Maile; C J Cross; G Czerniawska-Mysik; A Szcezklik
Pharmacological attempts to modulate leukotriene synthesis in aspirin-induced asthma.
Agents and actions. Supplements 1987;21():203-13.
1987: Andrew Szczeklik; Ryszard Dworski; Ewa Nizankowska; P Gajewski
Effects of inhibition of thromboxane A2 synthesis in aspirin-induced asthma.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17B():1073-9.
1986: Ewa Nizankowska; G Czerniawska-Mysik; Andrew Szczeklik
Lack of effect of i.v. prostacyclin on aspirin-induced asthma.
European journal of respiratory diseases 1986;69(5):363-8.
1986: A Szczeklik; R J Gryglewski; G Czerniawska-Mysik; Ewa Nizankowska
Aspirin sensitive asthma and arachidonic acid transformation.
New England and regional allergy proceedings 1986;7(1):21-5.
1985: Andrew Szczeklik; Ewa Nizankowska; G Czerniawska-Mysik; S Sek
Hydrocortisone and airflow impairment in aspirin-induced asthma.
The Journal of allergy and clinical immunology 1985;76(4):530-6.
1985: Ewa Nizankowska; A Q Sheridan; M H Maile; C J Cross; R Nizankowski; K Prochowska; A Szczeklik
Bronchodilatory properties of 2-decarboxy-2-hydroxymethyl prostaglandin E1.
Prostaglandins 1985;29(3):349-62.
1980: Andrew Szczeklik; G Czerniawska-Mysik; Ewa Nizankowska
Sulfinpyrazone and aspirin-induced asthma.
The New England journal of medicine 1980;303(12):702-3.
1980: Andrew Szczeklik; R J Gryglewski; G Czerniawska-Mysik; Ewa Nizankowska
Aspirin, prostaglandins, and bronchial asthma.
Advances in prostaglandin and thromboxane research 1980;7():993-4.